Skip to content

Level 3 · The framing — two regimes and 'watch, don't run'

Levels 1 and 2 were the spine: a high-risk AI system answering to the EU AI Act and nothing stacked above it. Level 3 is your first overlay — a system that is high-risk under the AI Act and carries a sectoral regime on top.

The system is a diabetic-retinopathy (DR) screener: it reads a fundus photograph and decides refer to an ophthalmologist / do not refer. That decision touches a patient’s sight, so it is high-risk under the EU AI Act. But notice how it becomes high-risk. Student selection was high-risk because of its use (Annex III §3, education). A retina screener is high-risk for a different reason: it is a safety component of a medical device, and the AI Act’s Art. 6(1) + Annex I route says that an AI system which is a safety component of a product already regulated by EU product-safety law (the MDR) is high-risk. So the very same fact — “this is a medical device” — does two things at once: it makes the system AI Act high-risk (via Art. 6(1)), and it makes the system an MDR medical device in its own right (Class IIa). One system, two regimes.

§2 — Which laws apply (and which don’t)

Section titled “§2 — Which laws apply (and which don’t)”

Be precise about scope — honesty cuts both ways.

  • EU AI Act — high-risk, via Art. 6(1) + Annex I. Nerea declares tier: high via the classify-system portal mission, with the basis spelled out in froga.yaml: “Art. 6(1) (safety component of a medical device — SaMD MDR Class IIa)”. That pulls the Articles 9–15 spine into scope.
  • MDR (Reg. EU 2017/745) — Class IIa medical device. Declared in applicable_standards as eu/mdr@2017. This is the overlay. But — and this is the crux of the level — the MDR is binding law, not a harmonised AI-risk-management standard cited for Article 9. The engine treats it differently: it emits a signed crosswalk mapping the system’s risks onto the MDR’s GSPR clauses, but it does not print an MDR conformity verdict and the MDR confers no presumption through the engine. Never say “MDR-governed”. (§6 shows exactly what the crosswalk looks like.)
  • No DORA. A credit model run by a bank would carry DORA (finance) on top of the AI Act. A retina screener does not: the operator is a clinic, not a financial entity, so DORA simply does not apply. Declaring it would be over-claiming a regime the system isn’t under. You meet DORA in the finance overlay (a later level).

The MDR being law, not a harmonised standard is why a notified body enters the picture at all. Self-declaration is only an option for the lowest device class (MDR Class I). A Class IIa device must go through the MDR conformity-assessment procedure (Art. 52), which requires an accredited, independent notified body to assess the evidence and certify it. The engine is not, and cannot be, that body.